跳至主要内容
临床试验/IRCT20210324050760N1
IRCT20210324050760N1尚未招募4 期

Evaluation of clinical course and disease consequences with or without Remdesivir intake in patients with COVID-19 infection

Shahre-kord University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Blood oxygen saturation<93% in room air or patients with patients in need of supportive oxygen or ventilation or
  • Patients with pulmonary infiltration in radiological studies

排除标准

  • Alanine aminotransferase and Aspartate aminotransferase rising more than 5 times the upper limit of normal
  • Glomerular filtration rate less than 30ml/minute(according to Cockroft-Gault formula)

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验

Effect of Remdesivir in treatment of COVID-19 | 临床试验